The Lived Experience of Lupus Flares: Features, Triggers, and Management in an Australian Female Cohort

Marline L Squance, Glenn E M Reeves, Howard Bridgman, Marline L Squance, Glenn E M Reeves, Howard Bridgman

Abstract

Individuals living with lupus commonly experience daily backgrounds of symptoms managed to acceptable tolerance levels to prevent organ damage. Despite management, exacerbation periods (flares) still occur. Varied clinical presentations and unpredictable symptom exacerbation patterns provide management and assessment challenges. Patient perceptions of symptoms vary with perceived impact, lifestyles, available support, and self-management capacity. Therefore, to increase our understanding of lupus' health impacts and management, it was important to explore lupus flare characteristics from the patient viewpoint. Lupus flares in 101 Australian female patients were retrospectively explored with the use of a novel flare definition. Qualitative methods were used to explore patient-perceived flare symptoms, triggers, and management strategies adopted to alleviate symptom exacerbations. A mean of 29.9 flare days, with 6.8 discrete flares, was experienced. The study confirmed that patients perceive stress, infection, and UV light as flare triggers and identified new potential triggers of temperature and weather changes, work, and chemical exposure from home cleaning. The majority of flares were self-managed with patients making considered management choices without medical input. Barriers to seeking medical support included appointment timings and past negative experiences reflecting incongruence between clinician and patient views of symptom impact, assessment, and ultimately flare occurrence.

References

    1. FitzGerald J. D., Grossman J. M. Validity and reliability of retrospective assessment of disease activity and flare in observational cohorts of lupus patients. Lupus. 1999;8(8):638–644. doi: 10.1191/096120399680411443.
    1. Reeves G. E. M. Update on the immunology, diagnosis and management of systemic lupus erythematosus. Internal Medicine Journal. 2004;34(6):338–347. doi: 10.1111/j.1444-0903.2004.00578.x.
    1. Lateef A., Petri M. Unmet medical needs in systemic lupus erythematosus. Arthritis Research and Therapy. 2012;14(supplement 4, article S4) doi: 10.1186/ar3919.
    1. Poser C. M., Paty D. W., Scheinberg L. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Annals of Neurology. 1983;13(3):227–231. doi: 10.1002/ana.410130302.
    1. Rheumatology ACo. Update of the 1982 American College of Rheumatology Revised Criteria for Classification of Systemic Lupus Erythematosus: Classification Criteria for Diagnosis of Systemic Lupus Erythematosus. 1997. .
    1. Gladman D. D., Goldsmith C. H., Urowitz M. B., et al. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) damage index for systemic lupus erythematosus international comparison. The Journal of Rheumatology. 2000;27(2):373–376.
    1. Isenberg D. A., Allen E., Farewell V., et al. An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA. Annals of the Rheumatic Diseases. 2011;70(1):54–59. doi: 10.1136/ard.2010.132068.
    1. Petri M., Orbai A.-M., Alarcõn G. S., et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis & Rheumatism. 2012;64(8):2677–2686. doi: 10.1002/art.34473.
    1. Ruperto N., Hanrahan L. M., Alarcón G. S., et al. International consensus for a definition of disease flare in lupus. Lupus. 2011;20(5):453–462. doi: 10.1177/0961203310388445.
    1. Yen J. C., Neville C., Fortin P. R. Discordance between patients and their physicians in the assessment of lupus disease activity: relevance for clinical trials. Lupus. 1999;8(8):660–670. doi: 10.1191/096120399680411362.
    1. Grootscholten C., Ligtenberg G., Derksen R. H. W. M., et al. Health-related quality of life in patients with systemic lupus erythematosus: development and validation of a lupus specific symptom checklist. Quality of Life Research. 2003;12(6):635–644. doi: 10.1023/A:1025176407776.
    1. Wiginton K. L. Illness representations: mapping the experience of lupus. Health Education & Behavior. 1999;26(4):443–453. doi: 10.1177/109019819902600403.
    1. Hewlett S., Sanderson T., May J., et al. “I'm hurting, I want to kill myself”: rheumatoid arthritis flare is more than a high joint count—an international patient perspective on flare where medical help is sought. Rheumatology. 2012;51(1):69–76. doi: 10.1093/rheumatology/keq455.
    1. Hanly J. G. Disease activity, cumulative damage and quality of life systematic lupus erythematosus: results of a cross-sectional study. Lupus. 1997;6(3):243–247. doi: 10.1177/096120339700600305.
    1. Kumar K., Gordon C., Barry R., Shaw K., Horne R., Raza K. 'It's like taking poison to kill poison but I have to get better': a qualitative study of beliefs about medicines in Rheumatoid arthritis and Systemic lupus erythematosus patients of South Asian origin. Lupus. 2011;20(8):837–844. doi: 10.1177/0961203311398512.
    1. Flurey C. A., Morris M., Richards P., Hughes R., Hewlett S. It's like a juggling act: rheumatoid arthritis patient perspectives on daily life and flare while on current treatment regimes. Rheumatology. 2014;53(4):696–703. doi: 10.1093/rheumatology/ket416.ket416
    1. Gallop K., Nixon A., Swinburn P., Sterling K. L., Naegeli A. N., Silk M. E. Development of a conceptual model of health-related quality of life for systemic lupus erythematosus from the patient's perspective. Lupus. 2012;21(9):934–943. doi: 10.1177/0961203312441980.
    1. Association WM. World Medical Association Declaration of Helsinki, 2008, .
    1. Israel B. A., Eng E., Schulz A. J., Parker E. A. Methods for Community-Based Participatory Research for Health. 1st. San Francisco, Calif, USA: John Wiley & Sons; 2005.
    1. Squance M. L., Guest M., Reeves G., Attia J., Bridgman H. Exploring lifetime occupational exposure and SLE flare: a patient-focussed pilot study. Lupus Science & Medicine. 2014;1(1) doi: 10.1136/lupus-2014-000023.e000023
    1. Braun V., Clarke V. Using thematic analysis in psychology. Qualitative Research in Psychology. 2006;3(2):77–101. doi: 10.1191/1478088706qp063oa.
    1. Sterling K. L., Gallop K., Swinburn P., et al. Patient-reported fatigue and its impact on patients with systemic lupus erythematosus. Lupus. 2014;23(2):124–132. doi: 10.1177/0961203313511554.
    1. Haga H.-J., Brun J. G., Rekvig O. P., Wetterberg L. Seasonal variations in activity of systemic lupus erythematosus in a subarctic region. Lupus. 1999;8(4):269–273. doi: 10.1191/096120399678847858.
    1. Goodman D., Morrissey S., Graham D., Bossingham D. Illness representations of systemic lupus erythematosus. Qualitative Health Research. 2005;15(5):606–619. doi: 10.1177/1049732305275167.
    1. Whitelaw D. A., Spangenberg J. J. An investigation in the possible effect of chronic headache on neuropsychological function in aCL-negative patients with SLE. Lupus. 2009;18(7):613–617. doi: 10.1177/0961203308101282.
    1. Pawlak C. R., Witte T., Heiken H., et al. Flares in patients with systemic lupus erythematosus are associated with daily psychological stress. Psychotherapy and Psychosomatics. 2003;72(3):159–165. doi: 10.1159/000069735.
    1. Somers E. C., Richardson B. C. Environmental exposures, epigenetic changes and the risk of lupus. Lupus. 2014;23(6):568–576. doi: 10.1177/0961203313499419.
    1. James J. A., Harley J. B., Scofield R. H. Epstein-barr virus and systemic lupus erythematosus. Current Opinion in Rheumatology. 2006;18(5):462–467. doi: 10.1097/01.bor.0000240355.37927.94.
    1. Baeke F., Takiishi T., Korf H., Gysemans C., Mathieu C. Vitamin D: modulator of the immune system. Current Opinion in Pharmacology. 2010;10(4):482–496. doi: 10.1016/j.coph.2010.04.001.
    1. Guillot X., Semerano L., Saidenberg-Kermanac'h N., Falgarone G., Boissier M.-C. Vitamin D and inflammation. Joint Bone Spine. 2010;77(6):552–557. doi: 10.1016/j.jbspin.2010.09.018.
    1. Gamez-Nava J. I., Gonzalez-Lopez L., Ramos-Remus C., Fonseca-Gomez M. M., Cardona-Muñoz E. G., Suarez-Almazor M. E. Autonomic dysfunction in patients with systemic lupus erythematosus. The Journal of Rheumatology. 1998;25(6):1092–1096.
    1. Mazzeo A., Stancanelli C., Di Leo R., Vita G. Autonomic involvement in subacute and chronic immune-mediated neuropathies. Autoimmune Diseases. 2013;2013:7. doi: 10.1155/2013/549465.549465
    1. Maule S., Quadri R., Mirante D., et al. Autonomic nervous dysfunction in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA): possible pathogenic role of autoantibodies to autonomic nervous structures. Clinical & Experimental Immunology. 1997;110(3):423–427. doi: 10.1046/j.1365-2249.1997.4501466.x.
    1. Kokolus K. M., Hong C.-C., Repasky E. A. Feeling too hot or cold after breast cancer: is it just a nuisance or a potentially important prognostic factor? International Journal of Hyperthermia. 2010;26(7):662–680. doi: 10.3109/02656736.2010.507235.
    1. Al Dhanhani A. M., Gignac M. A. M., Jiandong S. U., Fortin P. R. Work disability in systemic lupus erythematosus. Arthritis Care & Research. 2009;61(3):378–385. doi: 10.1002/art.24347.
    1. Baker K., Pope J. Employment and work disability in systemic lupus erythematosus: a systematic review. Rheumatology. 2009;48(3):281–284. doi: 10.1093/rheumatology/ken477.
    1. Hess E. V. Environmental chemicals and autoimmune disease: cause and effect. Toxicology. 2002;181-182:65–70. doi: 10.1016/S0300-483X(02)00256-1.
    1. Miller F. W. Environmental agents and autoimmune diseases. Advances in Experimental Medicine and Biology. 2011;711:61–81. doi: 10.1007/978-1-4419-8216-2_6.
    1. Parks C. G., Walitt B. T., Pettinger M., et al. Insecticide use and risk of rheumatoid arthritis and systemic lupus erythematosus in the women's health initiative observational study. Arthritis Care and Research. 2011;63(2):184–194. doi: 10.1002/acr.20335.
    1. Neville C., Clarke A. E., Joseph L., Belisle P., Ferland D., Fortin P. R. Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity. The Journal of Rheumatology. 2000;27(3):675–679.
    1. Hale E. D., Treharne G. J., Lyons A. C., et al. “Joining the dots” for patients with systemic lupus erythematosus: personal perspectives of health care from a qualitative study. Annals of the Rheumatic Diseases. 2006;65(5):585–589. doi: 10.1136/ard.2005.037077.
    1. Brown S. Coping with SLE: just in case vs. just in time: nurse's perspective. Lupus. 2013;22(12):1320–1323. doi: 10.1177/0961203313501399.
    1. Moses N., Wiggers J., Nicholas C. Persistence of unmet need for care among people with systemic lupus erythematosus: a longitudinal study. Quality of Life Research. 2008;17(6):867–876. doi: 10.1007/s11136-008-9361-2.
    1. Oliveira-Santos M., Verani J. F. S., Klumb E. M., Albuquerque E. M. N. Evaluation of adherence to drug treatment in patients with systemic lupus erythematosus in Brazil. Lupus. 2011;20(3):320–329. doi: 10.1177/0961203310383736.
    1. Chambers S. A., Raine R., Rahman A., Isenberg D. Why do patients with systemic lupus erythematosus take or fail to take their prescribed medications? A qualitative study in a UK cohort. Rheumatology. 2009;48(3):266–271. doi: 10.1093/rheumatology/ken479.
    1. Moore A. D., Petri M. A., Manzi S., et al. The use of alternative medical therapies in patients with systemic lupus erythematosus. Trination Study Group. Arthritis & Rheumatology. 2000;43(6):1410–1418.

Source: PubMed

3
Abonneren